BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37487468)

  • 1. Your Family Connects: A Theory-Based Intervention to Encourage Communication about Possible Inherited Cancer Risk among Ovarian Cancer Survivors and Close Relatives.
    Zhao J; McBride CM; Campbell GP; Pentz RD; Escoffery C; Konomos M; Bellcross C; Ward K; Shepperd JR; Guan Y
    Public Health Genomics; 2023; 26(1):77-89. PubMed ID: 37487468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Management of Patients with RPE65 Mutation Associated Inherited Retinal Degenerations in Europe: Results of a 2-Year Follow-Up Multinational Survey.
    Lorenz B; Tavares J; van den Born LI; Marques JP; Pilotto E; Stingl K; Charbel Issa P; Leroux D; Dollfus H; Scholl HPN
    Ophthalmic Res; 2023; 66(1):727-748. PubMed ID: 36878196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Publication Rates and Characteristics of Clinical Trials in Deep Brain and Responsive Neurostimulation.
    Chua MMJ; Warren AEL; Cosgrove GR; Rolston JD
    Stereotact Funct Neurosurg; 2023; 101(5):287-300. PubMed ID: 37552969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applying citizen science to engage families affected by ovarian cancer in developing genetic service outreach strategies.
    McBride CM; Campbell GP; Zhao J; Pentz RD; Escoffery C; Komonos M; Cannova K; Byrne JLB; Paris NM; Shepperd JR; Guan Y
    PLoS One; 2022; 17(2):e0262575. PubMed ID: 35157722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Management of Inherited Retinal Degeneration Patients in Europe: Results of a 2-Year Follow-Up Multinational Survey by the European Vision Institute Clinical Research Network - EVICR.net.
    Lorenz B; Tavares J; van den Born LI; Marques JP; Pilotto E; Stingl K; Charbel Issa P; Leroux D; Dollfus H; Scholl HPN; ;
    Ophthalmic Res; 2023; 66(1):550-568. PubMed ID: 36592621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitrite Interference with Soluble COD Measurements from Aerobically Treated Wastewater.
    Ferraz FM; Yuan Q
    Water Environ Res; 2017 Jun; 89(6):549-554. PubMed ID: 28545606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of the POD Function and the LOD of a Binary Microbiological Measurement Method from an Interlaboratory Experiment.
    Jarvis B; Wilrich C; Wilrich PT
    J AOAC Int; 2019 Sep; 102(5):1617-1623. PubMed ID: 31113528
    [No Abstract]   [Full Text] [Related]  

  • 9. Simultaneous Bioreduction of Multiple Oxidized Contaminants Using a Membrane Biofilm Reactor.
    Li H; Lin H; Xu X; Jiang M; Chang CC; Xia S
    Water Environ Res; 2017 Feb; 89(2):178-185. PubMed ID: 27196401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recruiting families at risk for hereditary breast and ovarian cancer from a statewide cancer registry: a methodological study.
    Katapodi MC; Duquette D; Yang JJ; Mendelsohn-Victor K; Anderson B; Nikolaidis C; Mancewicz E; Northouse LL; Duffy S; Ronis D; Milliron KJ; Probst-Herbst N; Merajver SD; Janz NK; Copeland G; Roberts S
    Cancer Causes Control; 2017 Mar; 28(3):191-201. PubMed ID: 28197806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using a state cancer registry to recruit young breast cancer survivors and high-risk relatives: protocol of a randomized trial testing the efficacy of a targeted versus a tailored intervention to increase breast cancer screening.
    Katapodi MC; Northouse LL; Schafenacker AM; Duquette D; Duffy SA; Ronis DL; Anderson B; Janz NK; McLosky J; Milliron KJ; Merajver SD; Duong LM; Copeland G
    BMC Cancer; 2013 Mar; 13():97. PubMed ID: 23448100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer Predisposition Cascade Screening for Hereditary Breast/Ovarian Cancer and Lynch Syndromes in Switzerland: Study Protocol.
    Katapodi MC; Viassolo V; Caiata-Zufferey M; Nikolaidis C; Bührer-Landolt R; Buerki N; Graffeo R; Horváth HC; Kurzeder C; Rabaglio M; Scharfe M; Urech C; Erlanger TE; Probst-Hensch N; Heinimann K; Heinzelmann-Schwarz V; Pagani O; Chappuis PO
    JMIR Res Protoc; 2017 Sep; 6(9):e184. PubMed ID: 28931501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of Different Electron Acceptors on the Anaerobic Degradation of Curly-Leaf Pondweed.
    Peng SC; Xu X; Ma D; Chen TH; Wang J
    Water Environ Res; 2016 Dec; 88(12):2257-2259. PubMed ID: 28061938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Communication and decision-making about seeking inherited cancer risk information: findings from female survivor-relative focus groups.
    Mellon S; Berry-Bobovski L; Gold R; Levin N; Tainsky MA
    Psychooncology; 2006 Mar; 15(3):193-208. PubMed ID: 16100704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using a Tailored Digital Health Intervention for Family Communication and Cascade Genetic Testing in Swiss and Korean Families With Hereditary Breast and Ovarian Cancer: Protocol for the DIALOGUE Study.
    Kim S; Aceti M; Baroutsou V; Bürki N; Caiata-Zufferey M; Cattaneo M; Chappuis PO; Ciorba FM; Graffeo-Galbiati R; Heinzelmann-Schwarz V; Jeong J; Jung MM; Kim SW; Kim J; Lim MC; Ming C; Monnerat C; Park HS; Park SH; Pedrazzani CA; Rabaglio M; Ryu JM; Saccilotto R; Wieser S; Zürrer-Härdi U; Katapodi MC
    JMIR Res Protoc; 2021 Jun; 10(6):e26264. PubMed ID: 34114954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cultural adaptations to a telephone genetic counseling protocol and booklet for Latina breast cancer survivors at risk for hereditary breast and ovarian cancer.
    Gómez-Trillos S; Graves KD; Fiallos K; Schwartz MD; Peshkin BN; Hamilton H; Sheppard VB; Vadaparampil ST; Campos C; Cupertino AP; Alzamora MC; Lynce F; Hurtado-de-Mendoza A
    Transl Behav Med; 2023 May; 13(5):297-308. PubMed ID: 36694918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended Family Outreach in Hereditary Cancer Using Web-Based Genealogy, Direct-to-Consumer Ancestry Genetics, and Social Media: Mixed Methods Process Evaluation of the ConnectMyVariant Intervention.
    Chen AT; Huey J; Coe S; Kaganovsky J; Malouf EA; Evans HD; Daker J; Harper E; Fordiani O; Lowe EE; Oldroyd CM; Price A; Roth K; Stoddard J; Crandell JN; Shirts BH
    JMIR Cancer; 2023 Apr; 9():e43126. PubMed ID: 37079361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients.
    Claes E; Evers-Kiebooms G; Boogaerts A; Decruyenaere M; Denayer L; Legius E
    Am J Med Genet A; 2003 Jan; 116A(1):11-9. PubMed ID: 12476445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.